Somaxon Pharmaceuticals Reports 2008 Third Quarter Financial ...
6 Nov 2008 ... Somaxon Pharmaceuticals Reports 2008 Third Quarter Financial Results. - SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (Nasdaq: ...
http://biz.yahoo.com/bw/081106/20081106005911.html?.v=1...
|
News: Somaxon Pharmaceuticals Reports 2008 Third Quarter Financial ...
Somaxon Pharmaceuticals Reports 2008 Third Quarter Financial Results. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business.
http://www.genengnews.com/news/bnitem.aspx?name=44952156&tax...
|
Somaxon Pharmaceuticals to Present at the Lazard Capital Markets ...
Somaxon Pharmaceuticals to Present at the Lazard Capital Markets 5th Annual Healthcare Conference. - SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals,
...
http://biz.yahoo.com/bw/081113/20081113006215.html?.v=1...
|
BioPortfolio - Somaxon Pharmaceuticals - Profile
View the current Somaxon Pharmaceuticals Page on BioPortfolio.com ... Somaxon is a specialty pharmaceutical company focused on the in-licensing and ...
http://www.bioportfolio.com/biocorporate/30248-Somaxon+Pharm...
|
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 ...
Somaxon Pharmaceuticals to Present at the Thomas Weisel 2008 Healthcare Conference and NewsMakers in the Biotech Industry Conference.
http://biz.yahoo.com/bw/080828/20080828006085.html?.v=1...
|
Somaxon Pharmaceuticals, Inc. Appoints Richard W. Pascoe as ...
Mr. Pascoe succeeds David F. Hale, who has served as Somaxon’s interim chief executive officer since January 2008. Mr. Hale will continue as the company’s
...
http://www.biospace.com/news_story.aspx?NewsEntityId=106087...
|
Somaxon Pharmaceuticals Announces the Appointment of Senior ...
Somaxon Pharmaceuticals Announces the Appointment of Senior Commercial Leadership. - SAN DIEGO--(BUSINESS WIRE)--Somaxon Pharmaceuticals, Inc. (Nasdaq:
SOMX ...
http://biz.yahoo.com/bw/080818/20080818005957.html?.v=1...
|
Somaxon Pharmaceuticals, Inc. Reports Positive Results From A ...
Somaxon Pharmaceuticals, Inc. today announced that oral nalmefene hydrochloride, an opiate antagonist under development by the company, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=25327...
|
BioPortfolio - Biocorporate Search California
Somaxon is a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases ...
http://www.bioportfolio.com/biocorporate/search/region/Calif...
|
Somaxon Pharmaceuticals, Inc. Says May Delay Approval Submission ...
On May 8, 2007, Somaxon received correspondence from the U.S. Food and Drug Administration (FDA) in which the FDA stated that the results of the company's
...
http://www.biospace.com/news_story.aspx?NewsEntityId=55557...
|
